Indication

Pseudomonas aeruginosa septicemia

Pseudomonas aeruginosa septicemia is a severe, life-threatening bloodstream infection and systemic dysregulated inflammatory response triggered by the opportunistic Gram-negative bacillus *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa septicemia

75 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Pseudomonas aeruginosa septicemia therapies.

Showing 64–72 of 75 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
AVET-NOVAPLUS

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
Hospira

GENTAMICIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
Hikma Pharmaceuticals USA

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa septicemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pseudomonas aeruginosa septicemia.

Pseudomonas aeruginosa septicemia is a severe, life-threatening bloodstream infection and systemic dysregulated inflammatory response triggered by the opportunistic Gram-negative bacillus *Pseudomonas aeruginosa*.

It predominantly affects hospitalized, critically ill, or immunocompromised individuals, including patients with profound neutropenia, extensive thermal burns, hematologic malignancies, or indwelling medical devices.

Pathophysiologically, the organism invades the vascular compartment—often seeding from primary pulmonary, urinary, surgical, or wound sources—releasing endotoxins and virulence factors that provoke systemic inflammation, microvascular thrombosis, tissue hypoperfusion, and multiorgan dysfunction.

Clinically, it presents with hemodynamic instability, high fevers or hypothermia, tachypnea, and characteristic dermatologic manifestations such as ecthyma gangrenosum, carrying a high risk of progression to refractory septic shock and mortality.

Personalize your experience

Follow Pseudomonas aeruginosa septicemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it